首页> 外文期刊>Sage Open Medicine >Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy:
【24h】

Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy:

机译:评估慢性阻塞性肺疾病治疗报告的药物不良反应的预期,严重性和严重性:

获取原文
获取外文期刊封面目录资料

摘要

Introduction:Adverse drug reactions can cause increased morbidity and mortality, and therefore information needs to be studied systematically. Little is known about the adverse drug reactions for chronic obstructive pulmonary disease therapy. The goal of this study is to assess the expectedness, seriousness and severity of adverse drug reactions during chronic obstructive pulmonary disease therapy based on their reporting in the national pharmacovigilance system.Methods:This was a prospective, observational, 1-year, real-life study about the pharmacotherapy of a sample of 390 chronic obstructive pulmonary disease patients. Prescribed medicines were systematized and national pharmacovigilance databases were searched for reported adverse drug reactions. The expectedness was evaluated through the review of the summary of product characteristics, the seriousness was evaluated by the clinicians based on the life threatening nature of the adverse drug reactions, and the severity was evaluated through Hartwig’s ...
机译:简介:药物不良反应会增加发病率和死亡率,因此需要系统地研究信息。对于慢性阻塞性肺疾病治疗的药物不良反应知之甚少。这项研究的目的是根据国家药物警戒系统中的报告评估慢性阻塞性肺疾病治疗期间药物不良反应的预期,严重性和严重性。方法:这是一项前瞻性,观察性,1年真实生活390例慢性阻塞性肺疾病患者的药物治疗研究。将处方药系统化,并搜索国家药物警戒数据库以查找报告的药物不良反应。通过对产品特性的总结进行审查来评估预期,由临床医生根据不良药物反应的威胁生命的性质来评估严重性,并通过Hartwig的...评估严重性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号